{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:29:59Z","timestamp":1792801799449,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.maturitas.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T04:15:41Z","timestamp":1373516141000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Tissue-selective estrogen complexes for postmenopausal women"],"prefix":"10.1016","volume":"76","author":[{"given":"Sebastian","family":"Mirkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Komm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2013.06.003_bib0005","first-page":"CD002978","article-title":"Oral oestrogen and combined oestrogen\/progestogen therapy versus placebo for hot flushes","author":"MacLennan","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0010","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/91.13.1131","article-title":"Risk of endometrial cancer following estrogen replacement with and without progestins","volume":"91","author":"Weiderpass","year":"1999","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","article-title":"The 2012 hormone therapy position statement of The North American Menopause Society","volume":"19","author":"North American Menopause Society","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/11316000-000000000-00000","article-title":"Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms","volume":"27","author":"Archer","year":"2010","journal-title":"Drugs and Aging"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0025","first-page":"S1","article-title":"Selective estrogen receptor modulators: from bench, to bedside, and back again","volume":"16","author":"Hall","year":"2008","journal-title":"Menopausal Medicine"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1089\/jwh.2011.3448","article-title":"The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms","volume":"21","author":"Kagan","year":"2012","journal-title":"Journal of Women's Health (Larchmt)"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0035","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study","volume":"23","author":"Miller","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0040","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial","volume":"23","author":"Silverman","year":"2008","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0045","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1210\/en.2008-0817","article-title":"The pairing of a selective estrogen receptor modulator, bazedoxifene, with conjugated estrogens as a new paradigm for the treatment of menopausal symptoms and osteoporosis prevention","volume":"149","author":"Kharode","year":"2008","journal-title":"Endocrinology"},{"issue":"February","key":"10.1016\/j.maturitas.2013.06.003_bib0050","article-title":"Endometrial profile of bazedoxifene acetate alone and in combination with conjugated equine estrogens in a primate model","author":"Ethun","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0055","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","article-title":"Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women","volume":"105","author":"Ronkin","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0060","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/gme.0b013e3181a816be","article-title":"Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0065","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e3181a818db","article-title":"Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women","volume":"16","author":"Archer","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1574884711308020006","article-title":"The discovery and development of Selective Estrogen Receptor Modulators (SERMs) for clinical practice","volume":"8","author":"Maximov","year":"2012","journal-title":"Current Clinical Pharmacology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1210\/me.2008-0366","article-title":"Differential biochemical and cellular actions of premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination","volume":"23","author":"Berrodin","year":"2009","journal-title":"Molecular Endocrinology"},{"issue":"Suppl. 2","key":"10.1016\/j.maturitas.2013.06.003_bib0080","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0378-5122(00)00110-9","article-title":"Recent insights into the varying activity of estrogens","volume":"34","author":"Dey","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0085","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bone.2011.05.024","article-title":"Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats","volume":"49","author":"Komm","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0090","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/en.2008-1210","article-title":"Effects of various selective estrogen receptor modulators with or without conjugated estrogens on mouse mammary gland","volume":"150","author":"Peano","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0095","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1210\/en.2012-1583","article-title":"Effects of the conjugated equine estrogen\/bazedoxifene tissue-selective estrogen complex (TSEC) on mammary gland and breast cancer in mice","volume":"153","author":"Song","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0100","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1210\/en.2012-2038","article-title":"Inhibitory effects of a bazedoxifene\/conjugated equine estrogen combination on human breast cancer cells in vitro","volume":"154","author":"Song","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0105","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1210\/me.2012-1031","article-title":"Research resource: transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM\/estrogen complexes","volume":"26","author":"Wardell","year":"2012","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/GME.0b013e318252e46d","article-title":"Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys","volume":"19","author":"Ethun","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0115","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.111.072249","article-title":"The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor alpha and cyclin D1","volume":"80","author":"Lewis-Wambi","year":"2011","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/1933719111431002","article-title":"Global profiling of TSEC proliferative potential by the use of a reporter mouse for proliferation","volume":"20","author":"Oliva","year":"2013","journal-title":"Reproduction Science"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0125","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1210\/en.2010-1010","article-title":"Treatment with bazedoxifene, a selective estrogen receptor modulator, causes regression of endometriosis in a mouse model","volume":"152","author":"Kulak","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0130","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.fertnstert.2009.05.093","article-title":"Bazedoxifene\/conjugated estrogens (BZA\/CE): incidence of uterine bleeding in postmenopausal women","volume":"92","author":"Archer","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/gme.0b013e3181b7c65f","article-title":"A randomized, placebo- and active-controlled trial of bazedoxifene\/conjugated estrogens for treatment of moderate to severe vulvar\/vaginal atrophy in postmenopausal women","volume":"17","author":"Kagan","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0140","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0145","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.fertnstert.2009.03.113","article-title":"Evaluation of bazedoxifene\/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile","volume":"92","author":"Lobo","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"October","key":"10.1016\/j.maturitas.2013.06.003_bib0150","article-title":"Effects of bazedoxifene\/conjugated estrogens on endometrial safety and bone in postmenopausal women","author":"Mirkin","year":"2012","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0155","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.fertnstert.2009.05.094","article-title":"Endometrial effects of a tissue selective estrogen complex containing bazedoxifene\/conjugated estrogens as a menopausal therapy","volume":"92","author":"Pickar","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0160","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/gme.0b013e3181a7df0d","article-title":"Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene\/conjugated estrogens: a randomized, controlled trial","volume":"16","author":"Pinkerton","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0165","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0170","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13697130903305627","article-title":"Effects of bazedoxifene\/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar\/vaginal atrophy","volume":"13","author":"Bachmann","year":"2010","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/GME.0b013e318271f5e7","article-title":"Breast density changes in a randomized controlled trial evaluating bazedoxifene\/conjugated estrogens","volume":"20","author":"Harvey","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0180","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":"Longitudinal analysis of the association between vasomotor symptoms and race\/ethnicity across the menopausal transition: study of women's health across the nation","volume":"96","author":"Gold","year":"2006","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0185","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/13697130701744696","article-title":"Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States","volume":"11","author":"Williams","year":"2008","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0190","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13697137.2012.717996","article-title":"Hot flush symptom-free days with bazedoxifene\/conjugated estrogens in postmenopausal women","volume":"16","author":"Yu","year":"2013","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0195","first-page":"1237","article-title":"Bazedoxifene\/conjugated estrogens (BZA\/CE): effect on sleep parameters in postmenopausal women","volume":"17","author":"Pinkerton","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0200","series-title":"Abstract presented at: the 13th World Congress on Menopause","article-title":"Direct and indirect effects of bazedoxifene\/conjugated estrogens on sleep disturbance","author":"Pinkerton","year":"2011"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0205","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7525-3-47","article-title":"Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review","volume":"3","author":"Utian","year":"2005","journal-title":"Health and Quality of Life Outcomes"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.sleep.2004.07.006","article-title":"Psychometric properties of the Medical Outcomes Study Sleep measure","volume":"6","author":"Hays","year":"2005","journal-title":"Sleep Medicine"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0215","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/gme.0b013e31803816b8","article-title":"Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ)","volume":"14","author":"Hill","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0220","first-page":"1219","article-title":"Menopause-related quality of life and satisfaction in postmenopausal women treated with bazedoxifene\/conjugated estrogens (BZA\/CE)","volume":"17","author":"Pinkerton","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0225","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/gme.0b013e31815a5168","article-title":"Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women","volume":"15","author":"Levine","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0230","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1743-6109.2009.01335.x","article-title":"Prevalence and impact of vaginal symptoms among postmenopausal women","volume":"6","author":"Santoro","year":"2009","journal-title":"The Journal of Sexual Medicine"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0235","unstructured":"National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. http:\/\/www.nof.org\/professionals\/pdfs\/NOF_ClinicianGuide2009_v7.pdf 2010."},{"key":"10.1016\/j.maturitas.2013.06.003_bib0240","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","article-title":"Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study","volume":"23","author":"Silverman","year":"2012","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0245","series-title":"Presented at: the 13th International Menopause Society World Congress on Menopause","article-title":"Long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: results of a 7-year, randomized, placebo-controlled study","author":"Palacios","year":"2011"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0250","series-title":"Guidance for Industry. Estrogen and Estrogen\/Progestin Drug Products to Treat Vasomotor Symptoms and Vulvar and Vaginal Atrophy Symptoms-Recommendations for Clinical Evaluation","author":"Food and Drug Administration","year":"2003"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0255","series-title":"Oral presentation at: the 4th Triennial Scientific Meeting of the Asia Pacific Menopause Federation","article-title":"Endometrial safety and bleeding profile of bazedoxifene paired with conjugated estrogens: results from 2 years of therapy","author":"Fenton","year":"2010"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0260","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.maturitas.2006.08.004","article-title":"Benefits and risks of long-term low-dose oral continuous combined hormone therapy","volume":"56","author":"van de Weijer","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0265","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.amjmed.2005.09.051","article-title":"Discontinuation of postmenopausal hormone therapy","volume":"118","author":"Grady","year":"2005","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ogc.2011.05.005","article-title":"The menopausal transition and cardiovascular risk","volume":"38","author":"Chae","year":"2011","journal-title":"Obstetrics and Gynecology Clinics of North America"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0275","doi-asserted-by":"crossref","first-page":"587","DOI":"10.33549\/physiolres.932313","article-title":"Natural postmenopause is associated with an increase in combined cardiovascular risk factors","volume":"61","author":"Lejskova","year":"2012","journal-title":"Physiological Research"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0280","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2474-11-130","article-title":"Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis","volume":"11","author":"Christiansen","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0290","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/AOG.0b013e31828c5974","article-title":"Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial","volume":"121","author":"Pinkerton","year":"2013","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/jgs.12281","article-title":"The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy","volume":"61","author":"Hodis","year":"2013","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0300","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.brainres.2010.10.076","article-title":"A \u201cwindow of opportunity:\u201d the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent","volume":"1379","author":"Hodis","year":"2011","journal-title":"Brain Research"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0305","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.maturitas.2010.05.009","article-title":"SERMs: progress and future perspectives","volume":"67","author":"Pickar","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0310","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jcp.54.6.435","article-title":"Hormone replacement therapy and the endometrium","volume":"54","author":"Feeley","year":"2001","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0315","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/gme.0b013e3181c4f1d6","article-title":"Endometrial safety: a key hurdle for selective estrogen receptor modulators in development","volume":"17","author":"Pinkerton","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0320","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1359\/jbmr.060312","article-title":"Effects of conjugated equine estrogen on risk of fractures and BMD in postmenopausal women with hysterectomy: results from the women's health initiative randomized trial","volume":"21","author":"Jackson","year":"2006","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.maturitas.2013.06.003_bib0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jsbmb.2009.11.003","article-title":"Gene expression profiling studies of three SERMs and their conjugated estrogen combinations in human breast cancer cells: insights into the unique antagonistic effects of bazedoxifene on conjugated estrogens","volume":"118","author":"Chang","year":"2010","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512213001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:58:32Z","timestamp":1759913912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512213001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0378512213001874"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.06.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue-selective estrogen complexes for postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2013.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}